References
- Adamson PB. (2006). Integrating device monitoring into the infrastructure and workflow of routine practice. Rev Cardiovasc Med 7 Suppl 1:S42–S46.
- Ali SM, Aijazi T, Axelsson K, Nur O, Willander M. (2011). Wireless remote monitoring of glucose using a functionalized ZnO nanowire arrays based sensor. Sensors (Basel) 11:8485–8496.
- Bruls DM, Evers TH, Kahlman JA, van Lankvelt PJ, Ovsyanko M, Pelssers EG, Schleipen JJ, de Theije FK, Verschuren CA, van der Wijk T, van Zon JB, Dittmer WU, Immink AH, Nieuwenhuis JH, Prins MW. (2009). Rapid integrated biosensor for multiplexed immunoassays based on actuated magnetic nanoparticles. Lab Chip 9:3504–3510.
- Cooper ME, Bonnet F, Oldfield M, Jandeleit-Dahm K. (2001). Mechanisms of diabetic vasculopathy: an overview. Am J Hypertens 14:475–486.
- Cooper ME, Johnston CI. (2000). Optimizing treatment of hypertension in patients with diabetes. JAMA 283:3177–3179.
- Di Serio F, Lovero R, Leone M, De Sario R, Ruggieri V, Varraso L, Pansini N. (2006). Integration between the tele-cardiology unit and the central laboratory: methodological and clinical evaluation of point-of-care testing cardiac marker in the ambulance. Clin Chem Lab Med 44:768–773.
- Dittmer WU, Evers TH, Hardeman WM, Huijnen W, Kamps R, de Kievit P, Neijzen JH, Nieuwenhuis JH, Sijbers MJ, Dekkers DW, Hefti MH, Martens MF. (2010). Rapid, high sensitivity, point-of-care test for cardiac troponin based on optomagnetic biosensor. Clin Chim Acta 411:868–873.
- Dunlay SM, Shah ND, Shi Q, Morlan B, VanHouten H, Long KH, Roger VL. (2011). Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes 4:68–75.
- Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752.
- Kashem A, Cross RC, Santamore WP, Bove AA. (2006). Management of heart failure patients using telemedicine communication systems. Curr Cardiol Rep 8:171–179.
- Mazze R, Akkerman B, Mettner J. (2011). An overview of continuous glucose monitoring and the ambulatory glucose profile. Minn Med 94:40–44.
- Meetoo D, McGovern P, Safadi R. (2007). An epidemiological overview of diabetes across the world. Br J Nurs 16:1002–1007.
- Penfornis A, Personeni E, Borot S. (2011). Evolution of devices in diabetes management. Diabetes Technol Ther 13 Suppl 1:S93–102.
- Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O’Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2007). Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115:e69–171.
- Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. (2002). The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 4:361–371.
- Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. (2001). More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 3:315–322.
- Wild S, Roglic G, Green A, Sicree R, King H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053.
- Wild SH, Forouhi NG. (2007). What is the scale of the future diabetes epidemic, and how certain are we about it? Diabetologia 50:903–905.